Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

This is the authors' abstract. We don't add key points for this paper.

Key Points Patients of minority race with myeloma have had less increase in population-level survival in the early 21st century than white patients. Data from clinical trials show that mortality is similar for minorities, suggesting the population-level difference is due to utilization.